Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference
Rhea-AI Summary
Bausch Health (NYSE:BHC) announced that management will participate in a fireside chat at the Barclays 30th Annual Leveraged Finance Conference in Austin, Texas on Tuesday, May 19, 2026 at 10:25 a.m. U.S. ET.
A live webcast and replay will be available on the company’s investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – BHC
In the May 13 session, BHC declined 2.22%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 29 | Q1 2026 earnings | Neutral | +2.3% | Reported higher revenue with major goodwill impairment and reaffirmed 2026 guidance. |
| Apr 14 | Product launch | Positive | -0.7% | U.S. online launch of Biafine Skin Recovery Emulsion via multiple channels. |
| Mar 31 | Earnings date set | Neutral | +7.4% | Announced date and time for first quarter 2026 financial results and call. |
| Mar 26 | Scholarship program | Positive | +0.8% | Launched 2026 ASPIRE HIGHER scholarships up to $10,000 each for six students. |
| Feb 23 | Device launch | Positive | -2.5% | Introduced Clear + Brilliant Touch laser in Canada after Health Canada approval. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent company news has generally produced modest single‑digit price moves, with limited follow‑through after operational or corporate updates.
This announcement continues a pattern of investor‑relations focused communication. In late March 2026, Bausch Health pre‑announced its Q1 results date, which saw a 7.36% move. The subsequent Q1 2026 earnings release on April 29 showed revenue of $2.52 billion with a large goodwill impairment but a 2.33% gain, while product and program news (scholarships, launches) around February–April drove smaller, mixed reactions between roughly -2.45% and 0.79%. Today’s conference participation fits that lower‑impact category of news.
Key Terms
leveraged finance financial
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Details
Date: Tuesday, May 19, 2026
Time: 10:25 a.m.
Webcast: http://ir.bauschhealth.com/events-and-presentations
A replay of the event will be available on the investor relations website following the event.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll free) | (908) 569-3692 |
BHC-FINANCIAL |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-to-participate-in-barclays-30th-annual-leveraged-finance-conference-302770033.html
SOURCE Bausch Health Companies Inc.
